Status:
COMPLETED
Non-Invasive Hemoglobin Monitoring of Women Undergoing Cesarean Delivery
Lead Sponsor:
Stony Brook University
Conditions:
Complications of Pregnancy, Childbirth and the Puerperium
Eligibility:
FEMALE
18-50 years
Brief Summary
The purpose of this study is to determine the normal hemoglobin curve during cesarean delivery and for the first 24 hours after surgery to aid in the creation of an algorithm to detect life-threatenin...
Detailed Description
Acute and life threatening blood loss is the most common cause of morbidity and mortality for pregnancy women in the US. To date, the only means we have of monitoring the amount of blood loss during a...
Eligibility Criteria
Inclusion
- Women undergoing scheduled cesarean delivery
Exclusion
- Blood disorders (i.e. thalassemia, sickle cell), hypertensive disorders, obstetric risk factors for hemorrhage
Key Trial Info
Start Date :
October 15 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 30 2016
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02275507
Start Date
October 15 2014
End Date
October 30 2016
Last Update
December 4 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stony Brook University Hospital
Stony Brook, New York, United States, 11794